{"doi":"10.1158/1078-0432.c.6532764","title":"Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer","abstract":"&lt;div&gt;AbstractPurpose:&lt;p&gt;Identification of inherited germline variants can guide personalized cancer screening, prevention, and treatment. Pathogenic and likely pathogenic (P/LP) germline variants in cancer predisposition genes are frequent among patients with locally advanced or metastatic urothelial carcinoma, but their prevalence and significance in patients with non–muscle-invasive bladder cancer (NMIBC), the most common form of urothelial carcinoma, is understudied.&lt;/p&gt;Experimental Design:&lt;p&gt;Germline analysis was conducted on paired tumor/normal sequencing results from two distinct cohorts of patients initially diagnosed with NMIBC. Associations between clinicopathologic features and clinical outcomes with the presence of P/LP germline variants in ≥76 hereditary cancer predisposition genes were analyzed.&lt;/p&gt;Results:&lt;p&gt;A similar frequency of P/LP germline variants were seen in our two NMIBC cohorts [12% (12/99) vs. 8.7% (10/115), &lt;i&gt;P&lt;/i&gt; = 0.4]. In the combined analysis, P/LP germline variants were found only in patients with high-grade NMIBC (22/163), but none of the 46 patients with low-grade NMIBC (13.5% vs. 0%, &lt;i&gt;P&lt;/i&gt; = 0.005). Fifteen (9.2%) patients with high-grade NMIBC had P/LP variants in DNA damage response genes, most within the nucleotide excision repair (&lt;i&gt;ERCC2/3&lt;/i&gt;) and homologous recombination repair (&lt;i&gt;BRCA1, NBN, RAD50&lt;/i&gt;) pathways. Contrary to prior reports in patients with NMIBC not receiving Bacillus Calmette-Guerin (BCG), P/LP germline variants were not associated with worse recurrence-free or progression-free survival in patients treated with BCG or with risk of developing upper tract urothelial carcinoma.&lt;/p&gt;Conclusions:&lt;p&gt;Our results support offering germline counseling and testing for all patients with high-grade bladder cancer, regardless of initial tumor stage. Therapeutic strategies that target impaired DNA repair may benefit patients with high-grade NMIBC.&lt;/p&gt;&lt;/div&gt;","journal":null,"year":2023,"id":405336,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8654,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":704740,"name":"Karissa Whiting","orcid":"0000-0002-4683-1868","position":1,"is_corresponding":false},{"id":626093,"name":"Preethi Srinivasan","orcid":"0000-0002-7137-3440","position":2,"is_corresponding":false},{"id":271416,"name":"Chaitanya Bandlamudi","orcid":"0000-0003-1108-4919","position":3,"is_corresponding":false},{"id":671902,"name":"Aliya Khurram","orcid":"0000-0003-3726-6382","position":4,"is_corresponding":false},{"id":74232,"name":"Vijai Joseph","orcid":"0000-0002-7933-151X","position":5,"is_corresponding":false},{"id":444445,"name":"Aleksandra Walasek","orcid":null,"position":6,"is_corresponding":false},{"id":934023,"name":"Emily Bochner","orcid":"0000-0002-3008-0262","position":7,"is_corresponding":false},{"id":345893,"name":"Timothy N. Clinton","orcid":"0000-0002-0616-6840","position":8,"is_corresponding":false},{"id":342649,"name":"Nima Almassi","orcid":"0000-0002-6307-9268","position":9,"is_corresponding":false},{"id":671899,"name":"Hong Truong","orcid":"0000-0002-0225-0148","position":10,"is_corresponding":false},{"id":934024,"name":"Manuel R. de Jesus Escano","orcid":"0000-0001-6347-4148","position":11,"is_corresponding":false},{"id":934025,"name":"Michal Wiseman","orcid":"0000-0003-0515-532X","position":12,"is_corresponding":false},{"id":2235,"name":"Diana Mandelker","orcid":"0000-0003-4154-0567","position":13,"is_corresponding":false},{"id":335055,"name":"Yelena Kemel","orcid":"0000-0002-5042-5651","position":14,"is_corresponding":false},{"id":150218,"name":"Liying Zhang","orcid":"0000-0003-4517-0751","position":15,"is_corresponding":false},{"id":457579,"name":"Michael F. Walsh","orcid":"0000-0001-5006-6778","position":16,"is_corresponding":false},{"id":381098,"name":"Karen A. Cadoo","orcid":"0000-0002-8384-7148","position":17,"is_corresponding":false},{"id":90753,"name":"Jonathan Coleman","orcid":"0000-0002-6428-7835","position":18,"is_corresponding":false},{"id":14313,"name":"Hikmat Al‐Ahmadie","orcid":"0000-0002-2938-6627","position":19,"is_corresponding":false},{"id":335058,"name":"Jonathan E. Rosenberg","orcid":"0000-0003-2637-4249","position":20,"is_corresponding":false},{"id":90739,"name":"Gopa Iyer","orcid":"0000-0002-5093-6099","position":21,"is_corresponding":false},{"id":75983,"name":"David B. Solit","orcid":"0000-0002-6614-802X","position":22,"is_corresponding":false},{"id":314353,"name":"Irina Ostrovnaya","orcid":"0000-0003-1783-0070","position":23,"is_corresponding":false},{"id":108795,"name":"Kenneth Offit","orcid":"0000-0002-2180-2032","position":24,"is_corresponding":false},{"id":90758,"name":"Mark E. Robson","orcid":"0000-0002-3109-1692","position":25,"is_corresponding":false},{"id":108796,"name":"Zsofia K. Stadler","orcid":"0000-0002-6985-2864","position":26,"is_corresponding":false},{"id":56288,"name":"Michael F. Berger","orcid":"0000-0003-3882-5000","position":27,"is_corresponding":false},{"id":108820,"name":"Dean F. Bajorin","orcid":"0000-0003-4001-7088","position":28,"is_corresponding":false},{"id":337832,"name":"Maria I. Carlo","orcid":"0000-0002-4786-7408","position":29,"is_corresponding":false},{"id":90774,"name":"Bernard H. Bochner","orcid":"0000-0003-0846-0848","position":30,"is_corresponding":false},{"id":270125,"name":"Eugene J. Pietzak","orcid":"0000-0002-5121-5701","position":0,"is_corresponding":true}],"reference_count":36,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T01:20:54.430249Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}